Breaking will pursue a human-body microplastic solution (supplement) in addition to environmental plastic degradation
Predictor: Ben Lamm · ep#245 "AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)" · source
Prediction text
Breaking will pursue a human-body microplastic solution (supplement) in addition to environmental plastic degradation | And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.
Verbatim quote
And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.
Predictor: Ben Lamm
Calibration plot (stated vs observed)
Evidence about this node from Ben Lamm is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).
Reference class
This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.
Probability over time
Milestone chain
- 2026-11-28pendingQ1 window check-in (25%)
- 2027-03-31pendingBreaking applies for or receives ARPA-H STOMP program fundingHow: ARPA-H STOMP awardee announcement names Breaking as recipient (program announced April 2026)Source: HHS press room ARPA-H STOMPconf 40%
- 2027-06-29pendingQ2 window check-in (50%)
- 2027-06-30pendingBreaking publishes preclinical paper or whitepaper on human-body microplastic supplementHow: Breaking (the company) publishes peer-reviewed preprint or company whitepaper on candidate molecule for in-vivo microplastic clearanceSource: Microplastic supplement startup space trackerconf 50%
- 2027-09-30pendingBreaking environmental product (plastic-degrading microbe) hits commercial scale milestoneHow: Breaking ships environmental degradation product to first municipal/industrial customer per company press releaseSource: Breaking core business prereqconf 50%
- 2027-06-01 → 2028-08-27pendingFirst peer-reviewed human RCT data on a microplastic-clearance interventionHow: Any peer-reviewed RCT (Breaking or competitor) reports change in serum/tissue microplastic concentration in N>=20 healthy adultsSource: Microplastics removal research pipelineconf 40%
- 2028-01-27pendingQ3 window check-in (75%)
- 2028-03-31pendingBreaking launches DTC supplement product or files IND with FDAHow: Breaking website publishes consumer supplement SKU OR FDA IND filing visible in clinicaltrials.gov for microplastic-clearance candidateSource: Industry trajectory — Washington Post coverage of microplastic clearance startupsconf 45%
No downstream cascades — this prediction is a leaf in the dependency graph.
What if this resolves?
Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"
Evidence chain
Network propagation neighbors
Top incoming (parents)
Edges that influence THIS node's belief
Top outgoing (children)
Predictions THIS node influences
No outgoing edges.
Ticker exposure
Beneficiaries (23)
Adverse (6)
Prerequisites (3)
Dependents (0)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| No dependents | ||||
Linked documents (6)
| Sim | Source | Title | Market prob | Polarity | Reviewed | Published |
|---|---|---|---|---|---|---|
| 0.575 | fda | FDA ANDA090431: DOXYCYCLINE HYCLATE (DOXYCYCLINE HYCLATE) — RISING | — | mentions | pending | 2026-04-09 |
| 0.572 | fda | FDA ANDA060469: TETRACYCLINE HYDROCHLORIDE (TETRACYCLINE HYDROCHLORIDE) — IMPAX LABS | — | mentions | pending | 2026-04-17 |
| 0.570 | fda | FDA ANDA210672: MULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — APOTEX | — | mentions | pending | 2026-04-09 |
| 0.568 | fda | FDA ANDA210273: MULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — APOTEX | — | mentions | pending | 2026-04-09 |
| 0.568 | fda | FDA ANDA090505: DOXYCYCLINE HYCLATE (DOXYCYCLINE HYCLATE) — IMPAX LABS INC | — | mentions | pending | 2026-04-09 |
| 0.513 | fda | FDA ANDA040719: METHYLPREDNISOLONE ACETATE (METHYLPREDNISOLONE ACETATE) — SANDOZ | — | mentions | pending | 2026-04-10 |
Raw metadata
{
"nia": false,
"url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
"mode": "ASPIRATION",
"role": "Guest-CEO",
"caveats": "Plastic problem requires myriad of different solutions",
"context": "And we are starting to look at the human body and and... you're not going to have like, you know, one solution to rule them all.",
"verbatim": "And we are starting to look at the human body and and... how do we break down and get rid of plastics um you know in the world.",
"conv_cues": "starting to look at",
"direction": "HAPPEN",
"timeframe": "Near future",
"conv_level": "MEDIUM",
"milestones": [
{
"kind": "quartile_checkpoint",
"label": "Q1 window check-in (25%)",
"status": "pending",
"weight": 0.05,
"ordinal": -8,
"source_id": null,
"expected_date": "2026-11-28",
"observed_date": null
},
{
"kind": "llm_pre_event",
"label": "Breaking applies for or receives ARPA-H STOMP program funding",
"source": "HHS press room ARPA-H STOMP",
"status": "pending",
"weight": 0.4,
"ordinal": -7,
"source_id": null,
"confidence": 0.4,
"source_url": "https://www.hhs.gov/press-room/arpa-h-launches-groundbreaking-144-million-program-combat-toxic-microplastics-human-body.html",
"expected_date": "2027-03-31",
"research_origin": "deep_research",
"measurement_criterion": "ARPA-H STOMP awardee announcement names Breaking as recipient (program announced April 2026)"
},
{
"kind": "quartile_checkpoint",
"label": "Q2 window check-in (50%)",
"status": "pending",
"weight": 0.05,
"ordinal": -6,
"source_id": null,
"expected_date": "2027-06-29",
"observed_date": null
},
{
"kind": "llm_pre_event",
"label": "Breaking publishes preclinical paper or whitepaper on human-body microplastic supplement",
"source": "Microplastic supplement startup space tracker",
"status": "pending",
"weight": 0.4,
"ordinal": -5,
"source_id": null,
"confidence": 0.5,
"source_url": "https://globalwellnessinstitute.org/global-wellness-institute-blog/2026/04/08/microplastics-watch-initiative-trends-for-2026/",
"expected_date": "2027-06-30",
"research_origin": "deep_research",
"measurement_criterion": "Breaking (the company) publishes peer-reviewed preprint or company whitepaper on candidate molecule for in-vivo microplastic clearance"
},
{
"kind": "llm_pre_event",
"label": "Breaking environmental product (plastic-degrading microbe) hits commercial scale milestone",
"source": "Breaking core business prereq",
"status": "pending",
"weight": 0.4,
"ordinal": -4,
"source_id": null,
"confidence": 0.5,
"expected_date": "2027-09-30",
"research_origin": "training",
"measurement_criterion": "Breaking ships environmental degradation product to first municipal/industrial customer per company press release"
},
{
"kind": "llm_post_event",
"label": "First peer-reviewed human RCT data on a microplastic-clearance intervention",
"source": "Microplastics removal research pipeline",
"status": "pending",
"weight": 0.4,
"ordinal": -3,
"source_id": null,
"confidence": 0.4,
"source_url": "https://www.themahareport.com/p/hhs-launches-144m-effort-to-confront",
"expected_date": "2028-01-13",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2028-08-27",
"from": "2027-06-01"
},
"measurement_criterion": "Any peer-reviewed RCT (Breaking or competitor) reports change in serum/tissue microplastic concentration in N>=20 healthy adults"
},
{
"kind": "quartile_checkpoint",
"label": "Q3 window check-in (75%)",
"status": "pending",
"weight": 0.05,
"ordinal": -2,
"source_id": null,
"expected_date": "2028-01
... (truncated)